Doppel Pharma Selects TraceLink to Comply with EU FMD Regulations; Companies Partner Together at CPhI Worldwide in Madrid
NORTH READING, Massachusetts, Oct. 9, 2018 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that Doppel Farma has selected TraceLink to comply with the EU Falsified Medicines Directive (FMD). TraceLink and Doppel will be partnering together to showcase their EU FMD serialization solution and services at CPhI Worldwide, October 9 – 11 in Madrid.
Based in Italy, Doppel is a contract development and manufacturing organization (CDMO) and one of Europe's leading experts in formulation, development and manufacturing. Doppel selected the TraceLink Life Sciences Cloud to enable its customers to meet the EU FMD deadline in February 2019, at the lowest cost and least risk to their product supply. By leveraging TraceLink's network tenant architecture, Doppel can eliminate the complexity and costs associated with point-to-point integrations for its EU pharmaceutical manufacturing customers.
"Many of our 90+ customers throughout Europe need to meet the FMD requirements. Therefore we could not approach this great effort with our strength only. Our analysis showed that individual point-to-point connections with each customer required a large amount of resources to an unpredictable guarantee of success. As a result, we selected TraceLink to save time and resources. With TraceLink's network approach, we will instantly transform our serialization project into a much easier and more manageable process," said Claudio Rondena, Business Manager at Doppel.
Visit TraceLink and Doppel at CPhI Worldwide October 9-11, 2018 in Madrid. To learn more about how to work with both TraceLink and Doppel to become EU FMD compliant, stop by stand 1K10.
Also at CPhI, TraceLink will be presenting in the Pharma Insights Briefing Room with Sharp Packaging Services on "Engaging the Patient: The opportunities & challenges of a fully serialization-enabled supply chain," scheduled for October 9 at 1:50 p.m. CEST.
About TraceLink
TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
Logo - https://mma.prnewswire.com/media/690309/TraceLink_Logo.jpg
Share this article